Interferon gamma release assays for Q fever: Evaluation of new test formats in exposure screening to C. burnetii

Interferon gamma release assays for Q fever: Evaluation of new test formats in exposure screening to C. burnetii - Q-detect 2.0: Evaluation of new test formats

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON52198

Enrollment

140

Registered

2020-09-14

Start date

2020-09-29

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q fever

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - At least 18 years old; - Able and willing to sign the informed consent form; - Coxiella IGRA testing previously performed at Innatoss as part of research or diagnostic activities

Exclusion criteria

Exclusion criteria: There are no specific criteria for subjects to be excluded from participation in this study.

Design outcomes

Primary

Measure	Time frame
Background-corrected Cb-specific IFNgamma production in the different test formats, and percentage of IGRA+ individuals in the different test formats based on pre-established cut-offs.	—

Secondary

Measure	Time frame
Background-corrected Cb-specific production of mediators induced down-stream of IFNgamma.	—

Countries

Netherlands

Outcome results